Forbes June 2, 2024
Joshua Cohen

Louisiana is criminalizing the abortion pills mifepristone and misoprostol, just two years after the Supreme Court ruling to overturn Roe versus Wade and leave decisions on abortion law to the states. The bill which passed the Louisiana legislature could make it very difficult for women and healthcare providers to access such medications, which have more uses than just abortion. Other state governments could soon follow Louisiana’s lead.

By effectively challenging decisions made decades ago by the Food and Drug Administration, the Louisiana bill and court rulings with a similar agenda set a precedent in which the agency’s regulatory authority could be subverted with respect to prescription drugs or medical technologies, at the discretion of lawmakers and judges.

“Controlled And Dangerous...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Govt Agencies, Patient / Consumer, Provider, States
Health care is Newsom's biggest unfinished project: Trump complicates that task
The first state to cover Ozempic under the ACA
States with the largest ACA enrollment increases | 2025
HHS grants 14 states funding for community behavioral health clinics
New York Gov. Kathy Hochul Announces 11 New CDPAP Partners

Share This Article